Aastrom Biosciences Reports Fourth Quarter and Fiscal Year 2010 Operating Results (Gl

[WTB RSS]

ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported operating results for the fourth quarter and fiscal year ended June 30, 2010.

More... (http://finance.yahoo.com/news/Aastrom-Biosciences-Reports-pz-3662822366.html?x=0)